SOCS3 deficiency-dependent autophagy repression promotes the survival of early-stage myeloid-derived suppressor cells in breast cancer by activating the Wnt/mTOR pathway
Journal of Leukocyte Biology · 2023
DOI: 10.1093/jleuko/qiad020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2023. Verfasst von Wenwen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's …. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Science Foundation, National Science and Technology Support Project of China.
Abstract (Originalsprache)
Early-stage myeloid-derived suppressor cells are a newly defined subset of myeloid-derived suppressor cells in breast cancer tissues and related to poor prognosis in patients with breast cancer. Compared with classical myeloid-derived suppressor cells, early-stage myeloid-derived suppressor cells display exceptional immunosuppressive ability and accumulate in the tumor microenvironment to suppress innate and adaptive immunity. Previously, we demonstrated that early-stage myeloid-derived suppressor cells were SOCS3 deficiency dependent and correlated with differentiation arrest in the myeloid lineage. Autophagy is a major regulator of myeloid differentiation, but the mechanism by which autophagy regulates the development of early-stage myeloid-derived suppressor cells has not been elucidated. Here, we constructed EO771 mammary tumor-bearing conditional myeloid SOCS3 knockout mice (SOCS3MyeKO) characterized by abundant tumor-infiltrating early-stage myeloid-derived suppressor cells and exacerbated immunosuppression in vitro and in vivo. We found that early-stage myeloid-derived suppressor cells isolated from SOCS3MyeKO mice showed differentiation arrest in the myeloid lineage, which was caused by limited autophagy activation in an Wnt/mTOR-dependent manner. RNA sequencing and microRNA microarray assays revealed that miR-155–induced C/EBPβ downregulation activated the Wnt/mTOR pathway and promoted autophagy repression and differentiation arrest in early-stage myeloid-derived suppressor cells. Furthermore, inhibition of Wnt/mTOR signaling suppressed both tumor growth and the immunosuppressive functions of early-stage myeloid-derived suppressor cells. Thus, SOCS3 deficiency-dependent autophagy repression and their regulatory mechanisms could contribute to the immunosuppressive tumor microenvironment. Our study proposes a novel mechanism for promoting early-stage myeloid-derived suppressor cell survival, which might shed new light on a potential target of oncologic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Huanhuxi Road, Hexi District, Tia…
- Department of Organ Transplantation Center, Tianjin First Central Hospital, School of Medicine, Nankai University, Fukang Road, Nankai District, Tianjin 300192, China.
- Department of Oncology, Tianjin Third Central Hospital, Jintang Road, Hedong District, Tianjin 300170, China.
- Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center f…
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Huanhuxi Road, H…
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research, Center for Cancer, Huanhuxi Road, Hexi District, Tianjin 300…
Förderung
- National Natural Science Foundation of China
- National Science Foundation
- National Science and Technology Support Project of China
- Project of Science and Technology of Tianjin
- Tianjin Research Innovation Project for Postgraduate Students
Zitieren
APA
Zhang, W., Li, X., Jiang, M., Ji, C., Chen, G., Zhang, Q., Liu, P., Zhang, R., Ren, X., Yu, W., & Yu, J. (2023). SOCS3 deficiency-dependent autophagy repression promotes the survival of early-stage myeloid-derived suppressor cells in breast cancer by activating the Wnt/mTOR pathway. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiad020
Vancouver
Zhang W, Li X, Jiang M, Ji C, Chen G, Zhang Q, et al. SOCS3 deficiency-dependent autophagy repression promotes the survival of early-stage myeloid-derived suppressor cells in breast cancer by activating the Wnt/mTOR pathway. Journal of Leukocyte Biology. 2023. doi:10.1093/jleuko/qiad020
BibTeX
@article{Zhang2023,
author = {Zhang, Wenwen and Li, Xingchen and Jiang, Mengmeng and Ji, Chenyan and Chen, Guidong and Zhang, Qiaoling and Liu, Pengpeng and Zhang, Rui and Ren, Xiubao and Yu, Wenwen and Yu, Jinpu},
title = {SOCS3 deficiency-dependent autophagy repression promotes the survival of early-stage myeloid-derived suppressor cells in breast cancer by activating the Wnt/mTOR pathway},
journal = {Journal of Leukocyte Biology},
year = {2023},
doi = {10.1093/jleuko/qiad020}
}
EUVIMED